Is there a Sasquatch?
According to Wikipedia; “In North American folklore, Bigfoot or Sasquatch are said to be hairy, upright-walking, ape-like creatures that dwell in the wilderness and leave footprints. They are strongly associated with the Pacific Northwest (particularly Oregon, Washington and British Columbia), and individuals claim to see the creatures across North America. Over the years, these creatures have inspired numerous commercial ventures and hoaxes.” We mention this as we are beginning to wonder if...
Yep it’s Friday
After we learned that Sanofi CEO Olivier Brandicourt was barely getting by on $8.2 million last year, a lode was lifted from our shoulders when we learned that Lilly CEO Dave Ricks racked in $17.3 million last year. Now we don’t know what Lars Fruergaard Jørgensen the CEO for Novo Nordisk took down last year but our guess he’s the same ballpark as Olivier and Mr. Ricks. Not that we...
Let’s look at this differently
This morning per a press release we learned; “EOFLOW CO., Ltd., an emerging medical device manufacturer with offices in Seoul, South Korea and San Jose, California, announced today that its closed loop Automated Insulin Delivery /Artificial Pancreas Device (AID/AP), the EOPancreas System, has received Breakthrough Device Designation by the U.S. Food and Drug Administration.” EOFLOW is just one of the many insulin pump wannabes seeking to enter the ever-crowded insulin pump market....
And so it goes …
Before we get into our regular post let’s a take a moment to reflect on the news that Sanofi CEO Olivier Brandicourt had to get by last year on a mere $8.2 million. Per SEC filings and a post on the FirecePharma web site; “Brandicourt’s total compensation actually fell in 2018, as the company suffered major sales declines in its flagship diabetes unit. The CEO’s pay package was slashed by 25%...
We need this why?
Years ago, before the invention of CGM we conducted an experiment. We visited several local pharmacies told the pharmacist that we were a newly diagnosed patient and our physician told us to get a meter. We asked of all the meters available which was the best. After getting a response we then asked which was the cheapest and what the difference was between the one the pharmacist recommended and the...
Best bet?
We’ve been getting lots of questions on which of the pure plays in diabetes are the best bets right now. As we noted the other day valuations by traditional measures have been cast aside as several of the pure plays in diabetes have seen their shares skyrocket. Just to be clear we define pure plays as any company whose main revenue steam and future business model is built substantially around...
This is NUTS!
Momma Kliff used to say that if you live long enough nothing much will shock you. Once again Mom was spot on for it looks as though Livongo has hired Morgan Stanley, Goldman Sachs Group and JP Morgan Chase to underwrite an IPO which, and we’d recommend sitting down for this one, would value the company in excess of $1 Billion. According to a story in today’s Wall Street Journal the...
Is it about patients or re-orders?
As the CGM market continues to mature it’s time to start looking at different metrics to measure success. Right now, the CGM market is following the early days of the insulin pump market. It’s all about how many patients a company can get onto their system. Yet as the pump market matured the story changed and it became not just how many new patients were added but also how many...
And the hits just keep on coming
This morning per a Tandem press release; “Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly identified during the ongoing DCLP3 phase of the International Diabetes Closed Loop (IDCL) clinical trial. The Company anticipates that the software update will be available to study...
Little news and BIG NEWS
This morning Senseonics announced that Dr. Francie Kaufman has been appointed Chief Medical Director. Per a company issued press release; “Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the appointment of Francine R. Kaufman, M.D. as Chief Medical Officer, effective immediately.” As everyone in the diabetes world knows Dr....